autologous NK cell plus GD2 antibody

1 treatment and condition followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

autologous NK cell plus GD2 antibody
Treatment and conditionWhere it standsTrials
autologous NK cell plus GD2 antibody for neuroblastomaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1